Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

How You Can Help

RSS NEWS FEED

Using Our Materials

---

Rules

Authors retain ownership of the copyright for all materials, but materials marked “Open Access” may be downloaded, reused, reprinted, modified, distributed, and/or copied, so long as the original source is cited. No permission is required.

For PharmedOut slideshows and factsheets, appropriate attribution can be provided by simply citing PharmedOut.org, Georgetown University Medical Center. For other Open Access materials, please cite the authors of those materials.

Our permissions policy is based on the Creative Commons Attribution License (summary.)

Requests

Rather than sending our materials to others, please direct people who want to view or use our materials to our website, so that we can keep track of how many times our materials are downloaded.

Although you’re not required to let us know, if you give a presentation using our slides, we would appreciate knowing where, when, and to whom. Feel free to share comments with us as well.

Pre and post-test evaluations are available for our slideshow; just contact us. If you use these with our presentation, please send us copies, as we are collating these data.

We may be able to provide PharmedOut pencils or post-it notes to distribute at presentations using our materials. Contact us about availability.

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Drug Firms Turn to Private Docs to Promote Products
University ethics policies tightened Milwaukee Journal Sentinel

---

J&J Pushed Risperdal After Warning, Files Show
FDA ignored; CME supported off-label uses Bloomberg

---

NIH Should Disclose Financial Conflicts
Public database requested Pharmalot

---

Diabetes Heart Treatments May Cause Harm
Normalizing BP and postprandial hyperglycemia don't help NYT

---

Grassley Tells PBMs To Disclose Ties To Pharma
Drugmakers may provide financial benefits Pharmalot

---

Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ

---

States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune

---

Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle

---

Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal

---

Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT

---

Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT

---

Commentary

Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum

---

Click HERE to read the entire news archives